BioNTech AG

BIONTECH

Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes;Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use;Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes;Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admission;